ArticleExperimental and therapeutic medicine2023

MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3.

Ju-Yeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.